Monica Slavin

Has grant

Professor

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Microbiology Microbiology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Monica Slavin is a Professor at the University of Melbourne, Australia. Her research areas include infectious diseases in immunocompromised patients, clinical outcomes post-transplantation, and antibiotic stewardship. She has recently published articles on viral infections after haematopoietic cell transplantation, antifungal prescribing practices, and the management of infections during novel myeloma therapies.

Recent Grants

Grant: Close

Lifting clinical trialls and registries capacity. An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies

Open Date: 2017-01-01

Close Date: 2020-01-01

Grant: Close

First in man trial of adoptive immunotherapy using fungus-specific T cells from a cryopreserved cell bank to treat invasive fungal disease after stem cell transplant

Open Date: 2017-01-01

Close Date: 2020-01-01

Grant: Close

Melbourne Genomics Health Alliance Flagship. Using pathogen genomics to reduce risk of hospital acquired “superbug” infections in high risk patients

Open Date: 2016-01-01

Close Date: 2018-01-01

Grant: Close

Australian Predicting Infectious ComplicatioNs In Children with Cancer (PICNICC) project

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

Centre for Improving Cancer Outcomes through Enhanced Infection Services

Open Date: 2016-01-01

Close Date: 2021-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (14)

PAOLO GROSSI

PROFESSORE DI I FASCIA

Università degli Studi di Roma La Sapienza

ITALY

View details

José María Aguado

SPAIN

View details

Miranda So

University of Toronto

CANADA

View details

Benjamin W Teh

University of Melbourne

AUSTRALIA

View details

Andrew Karaba

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Nicolas J Mueller

Head

University Hospital of Zurich

SWITZERLAND

View details

Karin Thursky

University of Melbourne

AUSTRALIA

View details

Dionysios Neofytos

University Hospital of Geneva

SWITZERLAND

View details

Lynette Chee

University of Melbourne

AUSTRALIA

View details

Daniel K. Yeoh

University of Western Australia

AUSTRALIA

View details

Natalie Rose Saunders

Murdoch Childrens Research Institute

AUSTRALIA

View details

Shahid Husain

University Health Network

CANADA

View details

J Peter Donnelly

Editor-in-Chief

British Society for Antimicrobial Chemotherapy

UNITED KINGDOM

View details

David J. Epstein

Stanford University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Monica Slavin

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Incidence and clinical outcomes of multiple viral infections after allogeneic haematopoietic cell transplantation

Current Practice Patterns and Educational Needs of Immunocompromised Infectious Diseases Physicians in Australia and New Zealand

Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre

Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals

Infections during novel myeloma therapies

The bottom line of CAR-T fungal risk: low incidence, high stakes and the need for individualised antifungal prophylaxis

Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey

Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T‐cell period: Preservation of vaccine‐associated antibodies between 0 and 6 months

Improving infection reporting in hematology treatment trials

JAC Supplement: ‘faster ID and AST revolution: how to improve antibiotic use in the critically ill’

American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients

Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients

Parvovirus B19 in stem cell transplantation

The antifungal pipeline for invasive fungal diseases: what does the future hold?

Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool

Invasive aspergillosis in liver transplant recipients

Invasive Scedosporium and Lomentospora prolificans Infections in Australia: A Multicenter Retrospective Cohort Study

Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation

When to change treatment of acute invasive aspergillosis: an expert viewpoint

Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study

Collaborators (14)

PAOLO GROSSI

José María Aguado

Miranda So

Benjamin W Teh

Andrew Karaba

Nicolas J Mueller

Karin Thursky

Dionysios Neofytos

Lynette Chee

Daniel K. Yeoh

Natalie Rose Saunders

Shahid Husain

J Peter Donnelly

David J. Epstein

Make your next move.